BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y2 receptor antagonist

British Journal of Pharmacology

Volumn 129, Issue 6, 2000, Pages 1075-1088

  Dumont, Yvan ^a   Cadieux, Alain ^b   Doods, Henri ^c   Pheng, Leng Hong ^b   Abounader, Roger ^d   Hamel, Edith ^d   Jacques, Danielle ^a   Regoli, Domenico ^b   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c Boehringer Ingelheim   (Germany)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Antagonist; Binding assay; Bioassay; NPY; Receptor subtype

Indexed keywords

N2 [[1 [2 [4 (5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL]PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL] N [2 (1,2 DIHYDRO 3,5 DIOXO 1,2 DIPHENYL 3H 1,2,4 TRIAZOL 4 YL]ETHYL]ARGINAMIDE; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN HOMOGENATE; COLON; DOG; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; KIDNEY CELL; MALE; MARMOSET; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SAPHENOUS VEIN; VAS DEFERENS;

EID: 0034021430     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703162     Document Type: Article

References (97)

1. 1 antagonist BIBP 3226. Br. J. Pharmacol., 116, 2245-2250.
2. BARRACO, R.A., ERGENE, E., DUNBAR, J.C. & EL-RIDI, M.R. (1990). Cardiorespiratory response patterns elicited by microinjections of neuropeptide Y in the nucleus tractus solitarius. Brain Res, Bull., 24, 465-485.
3. 1 receptor. Eur. J. Pharmacol., 316, 59-64.
4. 1 receptor antagonist, inhibits the vasoconstrictor effect on neuropeptide Y in the hamster microcirculation. Eur. J. Pharmacol., 319, 43-47.
5. BLOMQVIST, A.G. & HERZOG, H. (1997). Y-receptor subtypes how many more? Trends Neurosci., 20, 294-298.
6. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
7. BURKHOFF, A., LINEMEYER, D.L. & SALON, J.A. (1998). Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat. Mol. Brain Res., 53, 311-316.
8. 1 receptor subtype. Regul. Pept., 46, 557-564.
9. CASTAN, I., VALET, P., VOISIN, T., QUIDEAU, N., LABURTHE, M. & LAFONTAN, M. (1992). Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes. Endocrinology, 131, 1970-1976.
10. 2 receptor. J. Med. Chem., 37, 2242-2248.
11. CHEN, G. & VAN DEN POL, A.N. (1996). Multiple NPY receptors coexist in pre-and postsynaptic sites: inhibition of GABA release in isolated self-innervating SCN neurons. J. Neurosci., 16, 7711-7724.
12. COLMERS, W.F. (1990). Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions. Ann. N. Y. Acad. Sci., 611, 206-218.
13. COLMERS, W.F. & BLEAKMAN, D. (1994). Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci., 17, 373-379.
14. 5 receptor. J. Clin. Invest., 102, 2136-2145.
15. DANIELS, A.J., MATTHEWS, J.E., SLEPETIS, R.J., JANSEN, M., VIVEROS, O.H., TADEPALLI, A., HARRINGTON, W., HEYER, D., LANDAVAZO, A. & LEBAN, J.J. (1995a). High-affinity neuropeptide Y receptor antagonists. Proc. Natl. Acad Sci. U.S.A., 92, 9067-9071.
16. DANIELS, A.J., MATTHEWS, J.E., VIVEROS, O.H., LEBAN, J.J., CORY, M. & HEYER, D. (1995b). Structure-activity relationship of novel pentapeptide neuropeptide Y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding. Mol. Pharmacol., 48, 425-432.
17. 2 receptor antagonist. Eur. J. Pharmacol., 384, R3-R5.
18. 1 receptor antagonist: a review of its pharmacological properties. Regul. Pept., 65, 71-77.
19. 1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther., 275, 136-142.
20. 5). Can. J. Physiol. Pharmacol., (In Press)
21. 3 receptor sub-type. Mol. Brain Res., 26, 320-324.
22. 5 receptor subtype in the rat brain. J. Neurosci., 18, 5565-5574.
23. 2 radioligands. J. Pharmacol. Exp. Ther., 272, 673-680.
24. 2 receptor radioligands. Synapse, 22, 139-158.
25. 5 receptors in rodents, guinea pig, and primates brains. J. Comp. Neurol., 402, 372-384.
26. DUMONT, Y., JACQUES, D., ST-PIERRE, J.A., TONG, Y., PARKER, R., HERZOG, H. & QUIRION, R. (2000a). Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains. In: Quirion, R., Hokfelt, T. & Borjklund, A. (eds). Handbook of Chemical Neuroanatomy. Elsevier Science Publishers: London. In Press.
27. DUMONT, Y., MARTEL. J.C., FOURNIER, A., ST-PIERRE, S. & QUIRION, R. (1992). Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol., 38, 125-167.
28. 4 receptors. Br. J. Pharmacol., 129, 37-46.
29. FLOOD, J.F., HERNANDEZ, E.N. & MORLEY, J.E. (1987). Modulation of memory processing by neuropeptide Y. Brain Res., 421, 280-290.
30. FOREST, M., MARTEL, J.C., ST-PIERRE, S., QUIRION, R. & FOURNIER, A. (1990). Structural study of the N-terminal segment of neuropeptide tyrosine. J. Med. Chem., 33, 1615-1619.
31. 1 receptor agonist. Proc. Natl. Acad. Sci. U.S.A., 87, 182-186.
32. GEHLERT, D.R. (1998). Multiple receptors for the pancreatic polypeptide (PP-fold) family, physiological implications. Proc. Soc. Exp. Biol. Med., 218, 7-22.
33. 2 receptor. Mol. Pharmacol., 49, 224-228.
34. 34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide I receptors. Eur. J. Pharmacol., 318, 485-490.
35. GEHLERT, D.R., SCHOBER, D.A., BEAVERS, L., GADSKI, R., HOFFMAN. J.A., SMILEY, D.L., CHANCE, R.E., LUNDELL, I. & LARHAMMAR, D. (1996a). Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol. Pharmacol., 50, 112-118.
36. GERALD, C., WALKER, M.W., CRISCIONE, L., GUSTAFSON, E.L., BATZL-HARTMANN, C., SMITH, K.E., VAYSSE, P., DURKIN, M.M., LAZ, T.M., LINEMEYER, D.L., SCHAFFHAUSER, A.O., WHITEBREAD, S., HOFBAUER, K.G., TABER, R.I., BRANCHEK, T.A. & WEINSHANK, R.L. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 382, 168-171.
37. 2 receptor subtype. J. Biol. Chem., 270, 26758-26761.
38. 3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Br. J. Pharmacol., 120, 481-487.
39. 2 receptor. Neuroreport, 7, 1315-1319.
40. GREGOR, P., FENG, Y., DECARR, L.B., CORNFIELD, L.J. & MCCALEB, M.L. (1996). Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue. J. Biol. Chem., 271, 27776-27781.
41. 2 antagonist. J. Biol. Chem., 272, 7699-7706.
42. 2 antagonist [Erratum]. J. Biol. Chem., 273, 7699.
43. GRUNDEMAR, L., WAHLESTEDT, C. & REIS, D.J. (1991). Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J. Pharmacol. Exp. Ther., 258, 633-638.
44. 1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology, 8, 357-363.
45. HEILIG, M. & WIDERLOV, E. (1995). Neurobiology and clinical aspects of neuropeptide Y. Crit. Rev. Neurobiol., 9, 115-136.
46. HIPSKIND, P.A., LOBB, K.L., NIXON, J.A., BRITTON, T.C., BRUNS, R.F., CATLOW, J., DIECKMAN-MCGINTY, D.K., GACKENHEIMER, S.L., GITTER, B.D., IYENGAR, S., SCHOBER, D.A., SIMMONS, R.M., SWANSON, S., ZARRINMAYEH, H., ZIMMERMAN, D.M. & GEHLERT, D.R. (1997). Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists. J. Med. Chem., 40, 3712-3714.
47. 2 receptor. Neuroreport, 7, 1249-1252.
48. INUI, A. (1999). Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol. Sci., 20, 43-46.
49. 3 receptors. Eur. J. Pharmacol., 278, R3-R5.
50. JACQUES, D., DUMONT, Y., FOURNIER, A. & QUIRION, R. (1997). Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience, 79, 129-148.
51. JOLICOEUR, F.B., MICHAUD, J.N., MENARD, D. & FOURNIER, A. (1991b). In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors. Brain Res. Bull., 26, 309-311.
52. JOLICOEUR, F.B., MICHAUD, J.N., RIVEST, R., MENARD, D., GAUDIN, D., FOURNIER, A. & ST-PIERRE, S. (1991a). Neurobehavioral profile of neuropeptide Y. Brain Res. Bull., 26, 265-268.
53. KALRA, S.P. & CROWLEY, W.R. (1984). Norepinephrine-like effects of neuropeptide Y on LH release in the rat. Life Sci., 35, 1173-1176.
54. KALRA, S.P. & CROWLEY, W.R. (1992). Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol., 13, 1-46.
55. 5 receptors are not involved in physiologically relevant feeding in rodents. Regul. Pept., 71, 212.
56. 1-like receptor in rodents. Regul. Pept., 75-76, 409-415.
57. KLAPSTEIN, G.J. & COLMERS, W.F. (1993). On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro. Hippocampus, 3, 103-111.
58. KLAPSTEIN, G.J. & COLMERS, W.F. (1997). Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J. Neurophysiol.,18, 1651-1661.
59. LABURTHE, M. (1990). Peptide YY and neuropeptide Y in the gut: availability, biological actions and receptors. Trends Endocrinol. Meta., 1, 168-174.
60. LABURTHE, M., CHENUT, B., ROUYER-FESSARD, C., TATEMOTO, K., COUVINEAU, A., SERVIN, A. & AMIRANOFF, B. (1986). Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide. Endocrinology, 118, 1910-1917.
61. LARHAMMAR, D. (1996). Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul. Pept., 65, 165-174.
62. 1 type receptor. J. Med. Chem., 38, 1150-1157.
63. 1 receptor antagonist BIBP 3226. Br. J. Pharmacol., 116, 2971-2982.
64. LUNDBERG, J.M., MODIN, A. & MALMSTROM, R.E. (1996). Recent developments with neuropeptide Y receptor antagonists. Trends Pharmacol. Sci., 17, 301-304.
65. 1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo. Br. J. Pharmacol., 121, 595-603.
66. MARTEL, J.C., FOURNIER, A., ST-PIERRE, S., DUMONT, Y., FOREST, M. & QUIRION, R. (1990). Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors. Mol. Pharmacol., 38, 494-502.
67. MATSUMOTO, M., NOMURA, T., MOMOSE, K., IKEDA, Y., KONDOU, Y., AKIHO, H., TOGAMI, J., KIMURA, Y., OKADA, M. & YAMAGUCHI, T. (1996). Inactivation of a novel neuropeptide Y/ peptide YY receptor gene in primate species. J. Biol. Chem., 271, 27217-27220.
68. 2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J. Neurophysiol., 76, 3159-3168.
69. MICHEL, M.C., BECK-SICKINGER, A., COX, H., DOODS, H.N., HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ, T. & WESTFALL, T. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
70. MODIN, A. (1994). Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide. Acta Physiol. Scand. Suppl., 622, 1-74.
71. MORLEY, J.E. & FLOOD, J.F. (1989). The effect of neuropeptide Y on drinking in mice. Brain Res., 494, 129-137.
72. NARVAEZ, J.A., AGUIRRE, J.A. & FUXE, K. (1993). Subpicomolar amounts of NPY(13-36) injected into the nucleus tractus solitarius of the rat counteract the cardiovascular responses to L-glutamate. Neurosci. Lett., 151, 182-186.
73. 2 receptor. Nature Med., 5, 1188-1193.
74. 1 receptor mediating vasoconstriction in human cerebral arteries. Neurosci. Lett., 204, 145-148.
75. NILSSON, T., YOU, J., SUN, X., HEDNER, T. & EDVINSSON, L. (1996b). Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation. Blood Press., 5, 164-169.
76. 4 receptor agonists. Eur. J. Pharmacol., 349, 97-105.
77. 2 receptor of neuropeptide Y. Eur. J. Pharmacol., 327, 163-167.
78. 4 receptors in the rat colon. Eur. J. Pharmacol., 374, 85-91.
79. 2+ entry. J. Neurosci., 17, 8169-8177.
80. QUIRION, R., ROBITAILLE, Y., MARTIAL, J., CHABOT, J.G., LEMOINE, P., PILAPIL, C. & DALPE, M. (1988). Human brain receptor autoradiography using whole hemisphere sections: a general method that minimizes tissues artefacts. Synapse, 1, 446-454.
81. 1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation. Eur. J. Pharmacol., 329, 79-83.
82. 1 receptor antagonist: BIBP3226. Eur. J. Pharmacol., 271, R11-R13.
83. 4) receptor. Peptides, 19, 537-542.
84. 2, and pancreatic polypeptide receptors. Ann. N.Y. Acad. Sci., 611, 35-47.
85. 1 receptor antagonist. FEBS Lett., 362, 192-196.
86. SERVIN, A.L., ROUYER-FESSARD, C., BALASUBRAMANIAM, A., SAINT, P.S. & LABURTHE, M. (1989). Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3′,5′-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors. Endocrinology, 124, 692-700.
87. STANLEY, B.G. & LEIBOWITZ, S.F. (1984). Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci., 35, 2635-2642.
88. 1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography. Mol. Brain Res., 34, 303-308.
89. 1 receptors by BIBP3226 in rat and human epithelial preparations. Eur. J. Pharmacol., 310, 55-60.
90. VEZZANI, A., SPERK, G. & COLMERS, W.F. (1999). Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci., 22, 25-30.
91. WAHLESTEDT, C. & REIS, D.J. (1993). Neuropeptide Y-related peptides and their receptors are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol., 33, 309-352.
92. WAHLESTEDT, C., YANAIHARA, N. & HAKANSON, R. (1986). Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul. Pept., 13, 307-318.
93. 1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol., 125, 549-555.
94. WIELAND. H.A., WILLIM, K. & DOODS, H.N. (1995). Receptor binding profiles of NPY analogues and fragments in different tissues and cell lines. Peptides, 16, 1389-1394.
95. WOLDBYE, D.P. (1998). Antiepileptic effects of NPY on pentylenetetrazole seizures. Regul. Pept., 75-76, 279-282.
96. 5-like receptors. Nat. Med., 3, 761-764.
97. 1 receptors. Am., J. Physiol., 270, H796-H800.